Pelthos Therapeutics PTHS
NYSE PTHS
$20.45 +0.19 (+0.94%)
As of: Oct 20, 2026 · 3:52 PM EDT

Pelthos Therapeutics (PTHS) Construction in Progress (2025)

Updated

Pelthos Therapeutics (PTHS) reported Construction in Progress of $1.74 million for Q3 2025.

Analysis

Pelthos Therapeutics (PTHS) Construction in Progress (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Pelthos Therapeutics 72.38 Mn -16.01 Mn 11.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.74 Mn
API Access

Pelthos Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=PTHS&period=max&api_key=YOUR_API_KEY